Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq

Zhu, 2020, Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes, Cell Metabol, 31, 1068, 10.1016/j.cmet.2020.04.021 Babadaei, 2020, The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets, J Biomol Struct Dyn, 1 Landi, 2020, The new challenge of geriatrics: saving frail older people from the SARS-COV-2 pandemic infection, J Nutr Health Aging, 24, 466, 10.1007/s12603-020-1356-x Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3 Abdi, 2020, Diabetes and COVID-19: a systematic review on the current evidences, Diabetes Res Clin Pract, 166, 10.1016/j.diabres.2020.108347 Pugliese, 2020, Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?, Acta Diabetol, 57, 1275, 10.1007/s00592-020-01586-6 Alkundi, 2020, Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single centre study, Diabetes Res Clin Pract, 165, 10.1016/j.diabres.2020.108263 Al-Mosawi, 2018, ECG markers of arrythmogenic risk relationships with pericardial fat volume and BMI in patients with coronary atherosclerosis, J Electrocardiol, 51, 569, 10.1016/j.jelectrocard.2018.03.008 Apicella, 2020, COVID-19 in people with diabetes: understanding the reasons for worse outcomes, Lancet Diabet. Endocrinol, 8, 782, 10.1016/S2213-8587(20)30238-2 Guo, 2020, Diabetes is a risk factor for the progression and prognosis of COVID-19, Diabet Metab Res Rev, 10.1002/dmrr.3319 Huang, 2020, Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression, Diabet Metab Syndr, 14, 395, 10.1016/j.dsx.2020.04.018 Singleton, 2020, Effect of intensive glycemic and blood pressure control on QT prolongation in diabetes: the ACCORD trial, Diabetes, 69, 2186, 10.2337/db20-0401 Crouse, 2020, Metformin use IS associated with reduced mortality IN a diverse population with COVID-19 and diabetes, medRxiv Kow, 2020, Metformin use amid coronavirus disease 2019 pandemic, J Med Virol, 10.1002/jmv.26090 Ursini, 2020, COVID-19 and diabetes: is metformin a friend or foe?, Diabetes Res Clin Pract, 164, 10.1016/j.diabres.2020.108167 Gao, 2020, Risk of metformin in patients with type 2 diabetes with COVID-19: a preliminary retrospective report, Clin Transl Sci, 10.1111/cts.12897 Hariyanto, 2020, Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection, Obes Med, 19 Katsiki, 2020, Anti-inflammatory properties of antidiabetic drugs: a "promised land" in the COVID-19 era?, J Diabet Complicat, 34, 10.1016/j.jdiacomp.2020.107723 Scheen, 2020, Metformin and COVID-19: from cellular mechanisms to reduced mortality, Diabetes Metab, 10.1016/j.diabet.2020.07.006 Kim, 2020, The clinical characteristics and outcomes of patients with moderate-to-severe coronavirus disease 2019 infection and diabetes in daegu, South Korea, Diabetes Metab J, 44, 602, 10.4093/dmj.2020.0146 Liu, 2019, Effect of dipeptidyl-peptidase-4 inhibitors on Creative protein in patients with type 2 diabetes: a systematic review and metaanalysis, Lipids Health Dis, 18, 144, 10.1186/s12944-019-1086-4 Salem, 2014, Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice, Am J Physiol Ren Physiol, 306, F629, 10.1152/ajprenal.00516.2013 Gheblawi, 2020, Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2, Circ Res, 126, 1456, 10.1161/CIRCRESAHA.120.317015 Chen, 2020, Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication, Diabetes Care, 43, 1399, 10.2337/dc20-0660 Mirani, 2020, Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in lombardy, Italy, Diabetes Care, 10.2337/dc20-1340